Genmab — Maj 2021
-
Lidt af en afslutning på ADS’en i går…
-
Med 7 solgte ADS
-
God morgen.
-
Stoxx: Europæisk healthcare aktier viser ny svaghed, var det den foreløbige top? https://www.proinvestor.com/investornyt/674631/stoxx-europaeisk-healthcare-aktier-viser-ny-svaghed-var-det-den-forelobige-top
-
God morgen.
-
Lad os
håbe det ikke -
bliver uvejr...
-
another Covid vaccine response trial from Novartis - Exploring the Immune Response to SARS-CoV-2/COVID-19 Vaccines in Patients With Relapsing Multiple Sclerosis (RMS) Treated With Ofatumumab (KYRIOS) https://clinicaltrials.gov/ct2/show/NCT04869358
-
we saw a few articles about this, Mayo Clinic now starting a trial - Daratumumab to Treat Active Lupus Nephritis https://clinicaltrials.gov/ct2/show/NCT04868838
-
God morgen.
-
Asien: Store regionale forskelle på lukkedag i Tokyo og Shanghai - NY https://www.proinvestor.com/investornyt/674685/asien-store-regionale-forskelle-pa-lukkedag-i-tokyo-og-shanghai-ny
-
Tirsdagens aviser med negative renter, grøn aftale og skattesag https://www.proinvestor.com/investornyt/674680/tirsdagens-aviser-med-negative-renter-gron-aftale-og-skattesag
-
Luften skal da vist tages helt ud af Genmab inden regnskab.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind